The Unfortunate Event - Extramedullary Myeloma Of The Urinary Tract
Article Sidebar
Main Article Content
Abstract
Multiple myeloma is a type of haematological malignancy that arises from the abnormal prolifera-
tion of plasma cells leading to excessive production of monoclonal immunoglobulins ( 1). These
antibody-secreting plasma cells are produced by the B-lymphocytes ( 2). They play an important
role in humoral immune response due to their ability to produce antibodies. As important as the
plasma cells are to the human body, they can be equally destructive in plasma cell neoplasms.
Multiple myeloma is the more commonly known name for plasma cell neoplasm which is an um-
brella term for a host of other disorders that are associated with clonal proliferation of plasma cells
which includes extramedullary myeloma. We would like to discuss a rare case of extramedullary
myeloma of the urinary tract in a 65 years old gentleman.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an open-access journal, which means that all content is freely available without charge to the user or his/her institution. Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author. This is under the BOAI definition of open access.
The journal is adopting the Creative Commons International Attribution 4. CC Attribution-NonCommercial 4.0CC BY-NC 4.0]
You are free to:
- Share— copy and redistribute the material in any medium or format
- Adapt— remix, transform, and build upon the material
- for any purpose
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
-
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- NonCommercial — You may not use the material for commercial purposes .
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation.
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
- https://creativecommons.org/licenses/by-nc/4.0/
References
He J, Yue X, He D, Zhao Y, Yang Y, Zheng G, et al. Multiple extramedullary-bone related
and/or extramedullary extraosseous are independent poor prognostic factors in patients
with newly diagnosed multiple myeloma. Frontiers in Oncology. 2021;11:668099.
Pioli PD. Plasma cells, the next generation: beyond antibody secretion. Frontiers in immunol-
ogy. 2019;10:2768.
Bladé J, Beksac M, Caers J, Jurczyszyn A, von Lilienfeld-Toal M, Moreau P, et al. Ex-
tramedullary disease in multiple myeloma: a systematic literature review. Blood Cancer
Journal. 2022;12(3):45.
Churg J, Gordon A. Multiple myeloma with unusual visceral involvement. Arch Path.
;34:546.
Varettoni M, Corso A, Pica G, Mangiacavalli S, Pascutto C, Lazzarino M. Incidence, presenting
features and outcome of extramedullary disease in multiple myeloma: a longitudinal study
on 1003 consecutive patients. Annals of Oncology. 2010;21(2):325-30.
Sevcikova S, Minarik J, Stork M, Jelinek T, Pour L, Hajek R. Extramedullary disease in multiple
myeloma–controversies and future directions. Blood reviews. 2019;36:32-9.
Su W, Zeng L, Zhao D, Fu Y, Tang J. Case Report: Plasmacytoma of External Urethral Meatus.
Frontiers in Endocrinology. 2022;13.
Farinola MA, Lawler LP, Rosenthal D. Plasmacytoma with involvement of the urinary bladder.
Report of a case diagnosed by urine cytology. Acta cytologica. 2003;47(5):787-91.
Igel TC, Engen DE, Banks PM, Keeney GL. Renal plasmacytoma: Mayo Clinic experience and
review of the literature. Urology. 1991;37(4):385-9.
López A, Méndez F, Puras-Báez A. Extramedullary plasmacytoma invading the bladder:
case report and review of the literature. In: Urologic Oncology: Seminars and Original
Investigations. vol. 21. Elsevier; 2003. p. 419-23.
Wen G, Wang W, Zhang Y, Niu S, Li Q, Li Y. Management of extramedullary plasmacytoma:
Role of radiotherapy and prognostic factor analysis in 55 patients. Chinese Journal of Cancer
Research. 2017;29(5):438.
Köse M, Buraniqi E, Akpinar TS, Kayacan SM, Tükek T. Relapse of multiple myeloma pre-
senting as extramedullary plasmacytomas in multiple organs. Case reports in hematology.
;2015.
Raghuram S, Faizal B, Sanjeevan K, Eapen M, Nair IR, Philip A, et al. Recurrent extramedullary
plasmacytomas without multiple myeloma: A case report with review of the literature.
Cancer Treatment and Research Communications. 2022;31:100550.
Qian Y, Qian Z, Zhao X, Pan W, Wei X, Meng H, et al. Successful treatment of re-
lapsed/refractory extramedullary multiple myeloma with anti-BCMA CAR-T cell therapy
followed by haploidentical hematopoietic stem cell transplantation: a case report and a
review of the contemporary literature. Frontiers in Medicine. 2021;8:649824.
Pour L, Sevcikova S, Greslikova H, Kupska R, Majkova P, Zahradova L, et al. Soft-tissue
extramedullary multiple myeloma prognosis is significantly worse in comparison to bone-
related extramedullary relapse. Haematologica. 2013;99(2):360.
Ju C, He J, Wang C, Sheng J, Jia J, Du D, et al. Current advances and future perspectives on
the functional roles and clinical implications of circular RNAs in esophageal squamous cell
carcinoma: more influential than expected. Biomarker Research. 2022;10(1):1-18.
Gagelmann N, Eikema DJ, Iacobelli S, Koster L, Nahi H, Stoppa AM, et al. Impact of ex-
tramedullary disease in patients with newly diagnosed multiple myeloma undergoing autolo-
gous stem cell transplantation: a study from the Chronic Malignancies Working Party of the
EBMT. Haematologica. 2018;103(5):890.
Li J, Shen KN, Huang WR, Li LH, Chen H, Chen WM, et al. Autologous stem cell trans-
plant can overcome poor prognosis in patients with multiple myeloma with extramedullary
plasmacytoma. Leukemia & Lymphoma. 2014;55(7):1687-90.
Wu P, Davies FE, Boyd K, Thomas K, Dines S, Saso RM, et al. The impact of extramedullary
disease at presentation on the outcome of myeloma. Leukemia & lymphoma. 2009;50(2):230-